Figure 3.
Gut microbiota changes in pediatric patients with hematological malignancies receiving lactoferrin or placebo supplementation during induction chemotherapy. Boxplots showing the relative abundance distribution of families (A) and genera (B) significantly differentially represented over time (PRE, before; POST, after), in relation to lactoferrin (LF) or placebo (PL) supplementation during induction chemotherapy (Wilcoxon test, * for p ≤ 0.05). Only taxa with relative abundance > 0.1% in at least 2 samples are shown.
